Cholestech Schedules Teleconference to Discuss Second Quarter 2001 Financial Results.Business Editors and Health/Medical Writers HAYWARD, Calif.--(BW HealthWire)--Oct. 20, 2000 Cholestech Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CTEC CTEC Course and Teacher Evaluation Council (Northwestern University, Office of the Register) CTEC Certified Technical Education Center CTEC Certified Technical Education Center (Microsoft) ) announced today that it will report its second quarter 2001 financial results before the open of regular trading on Wednesday, October 25, 2000. The news release will be followed by a teleconference available to all interested parties at 7:00 a.m. PDT PDT abbr. Pacific Daylight Time PDT Pacific Daylight Time PDT n abbr (US) (= Pacific Daylight Time) → hora de verano del Pacífico PDT . The Cholestech Quarterly Results may be accessed via:
News Release:
Call Kalt Rosen & Co. (415-397-2686) to have a copy of the news
release faxed or visit the Cholestech website.
Teleconference:
Dial 800-633-8414 prior to the start of the call at 7:00 a.m.
PDT/10:00 a.m. EDT.
Note: If the number of lines allocated to the call are exhausted,
the webcast or replay should be utilized.
Internet Simulcast: www.cholestech.com
Replay:
The teleconference will be rebroadcast until 9:00 a.m. PDT,
Thursday, November 1, 2000 and can be accessed by:
-- Dialing 800-633-8284 and entering reservation No. 16573706
or
-- Clicking on the "Quarterly Conference Call" icon on the
company's website.
Additional information on Cholestech can be obtained on the company's website or by calling Kalt Rosen & Co. at (415) 397-2686. About Cholestech Cholestech is committed to helping people successfully improve their health. Cholestech's business units -- Diagnostic Products, WellCheck(TM), and WellCheck.com - combine to provide simple, accessible, and reliable personal health information to consumers and health care practitioners around the world. Risk assessment and therapeutic monitoring using the Cholestech L-D-X(R) System helps reduce risk of cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease , diabetes, and liver disease Liver Disease Definition Liver disease is a general term for any damage that reduces the functioning of the liver. Description The liver is a large, solid organ located in the upper right-hand side of the abdomen. . The WellCheck(TM) national testing service allows for convenient consumer testing for a number of chronic conditions, including high cholesterol Cholesterol, High Definition Cholesterol is a fatty substance found in animal tissue and is an important component to the human body. It is manufactured in the liver and carried throughout the body in the bloodstream. , hypertension, blood sugar, and osteoporosis osteoporosis (ŏs'tēō'pərō`sĭs), disorder in which the normal replenishment of old bone tissue is severely disrupted, resulting in weakened bones and increased risk of fracture; osteopenia . Consumers may enroll in WellCheck.com, a unique personal health management web site that provides interactive tools for assessing risk and monitoring progress in the management of whole-blood cholesterol levels and other lifestyle changes. Working together with health care providers, our goal is to ultimately enable people to lead longer, healthier, and more active lives. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion